HIGHLIGHTS OF PRESCRIBING INFORMATION DOSAGE AND ADMINISTRATION ADVERSE REACTIONS

First Page		Document Content
Date: 2014-08-21 13:04:53 Olopatadine Contact lens Alcohols Azelastine Chemistry Organic chemistry Amines		HIGHLIGHTS OF PRESCRIBING INFORMATION DOSAGE AND ADMINISTRATION ADVERSE REACTIONS Add to Reading List Source URL: ecatalog.alcon.com Download Document from Source Website File Size: 439,27 KB Share Document on Facebook

	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ASTEPRO® safely and effectively. See full prescribing information for ASTEPRO®. ASTEPRO (azelastine hydrochloride) DocID: 1l4l8 - View Document
	Azelastine Hydrochloride Ophthalmic Solution, 0.05% INRev. 5/10 DocID: 1k7xj - View Document
	Press release, February 27, 2015 DYMISTA® (azelastine hydrochloride and fluticasone propionate) approved in children 6 to 11 years of age with seasonal allergic rhinitis Meda announces the FDA approval of Dymista, a si DocID: 1jC3T - View Document
	Azelastine Hydrochloride 0.1% Nasal Spray Azelastine Hydrochloride 0.15% Nasal Spray INHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Azelastine DocID: 1gL9e - View Document
	DOC Document DocID: 13hwP - View Document